This weekly email delivers timely College news and a curated roundup of key articles and resources to keep you current, including breaking news, anecdotes from esteemed practitioners, insight into matters that affect the profession, and direct access to online education tools.
- Show all
- A Word from the President
- Annual Meeting
- Coding Conundrums
- Community Advantage
- Editorials from the Executive Medical Director
- High-five
- House of Delegates
- In Memoriam
- In My Opinion
- Medicare
- Practice Excellence
- Practice Management Advantage
- Spotlight on Annals
- Summation of COVID-19 Federal Responses
- Washington Perspectives
- Show all
- A/I Action
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- Committees
- COVID-19
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Member benefit
- New Allergists
- News
- Opinion
- Patient Brochures
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
Get ready for Asthma and Allergy Awareness month 2024
Be prepared for this awareness month, when attention is focused on asthma and allergies. It’s a great opportunity to share your expertise!
Nominate a FIT for 2024 Annals Award
FITs who publish the best original research or review in Annals will receive a cash award of up to $2,500. Multiple winners are possible.
AllergyWatch covers important ABAI CAP articles
Did you complete the most recent ABAI CAP cycle? Were you able to read all of the key articles in the program?
ACAAI practice manager membership
Is your practice manager/administrator a member of the College? If not, you’re missing an opportunity to elevate your practice – for free!
March 2024 Annals highlights
This month’s articles and reviews provide guidance for these changes in our treatment pathways.
AllergyTalk podcast features OUtMATCH study
The FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.
It takes a village
What does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning takes years to prepare.
Addressing Cannabis use with patients
A survey revealed 75% of surveyed allergists were only somewhat knowledgeable about respiratory effects and allergic reactions to cannabis
Coding for E&M visit and allergy testing on the same day
Many third-party payers insist skin tests are a part of an office visit, but this is not the case, and these denials should be appealed.
Take the College’s updated Practice Assessment Quiz!
The College has good news for you: our newly updated Practice Assessment Quiz makes assessing your allergy practice easier.